Rutgers University Foundation

Rutgers University Foundation

Established in 1973, Rutgers University Foundation is the dedicated philanthropic arm that generates and stewards private support for Rutgers, The State University of New Jersey. President Kimberly A. Hopely oversees an organization that bridges 617,000 alumni worldwide — 378,900 of them in New Jersey — with the university's academic, research, and healthcare ambitions. This is not the university's endowment manager; that is the separate Rutgers University Investment Office, led by Chief Investment Officer Jason MacDonald. The foundation's role is to aggregate gifts and grants that flow into the Long-Term Investment Pool and other university priorities. Donor-directed capital moves across three campus ecosystems in New Brunswick, Newark, and Camden, with healthcare a defining axis. Rutgers Health hosts New Jersey's only NCI-designated Comprehensive Cancer Center, supported by vehicles like the Fund for Rutgers Cancer Institute. Strategic deployments extend through partnerships with RWJBarnabas Health — creating the state's largest academic health care system — and international research collaborations with entities such as Tel Aviv University on Alzheimer's disease. While the Investment Office sets asset allocation for the pooled endowment, the foundation's deployment posture centers on programmatic grants, student success initiatives like Scarlet Promise Grants, and real estate holdings including One Washington Park in Newark and the Gateway Transit Village in New Brunswick. Beyond the central New Brunswick headquarters, the foundation stewards physical assets including the Rutgers Alumni House at Van Nest Hall and the Zimmerli Art Museum Collection. Alumni engagement remains a core function, with the foundation serving as the home of the Rutgers University Alumni Association. In May 2026, the foundation inducted five alumni into the Hall of Distinguished Alumni, a signal of its ongoing focus on donor cultivation and community building. No separate venture arm or co-investment club is disclosed; the giving architecture channels support through defined funds — the Edge Fund for non-traditional student talent, Scarlet Promise for financial aid, and the Fund for Rutgers Cancer Institute for oncology research. Structurally, the foundation's distinction lies in its separation of fundraising from investment management. Unlike a single family office that collapses origination and deployment, Rutgers' model splits philanthropic sourcing (Hopely's foundation) from institutional portfolio management (MacDonald's Investment Office). That separation means donors give to a 501(c)(3) with programmatic purview, while the university's endowment benefits from dedicated investment governance — a bifurcated architecture that shields asset allocation from fundraising cycles.